Tribute Pharmaceuticals Canada (SLRXF) 10-Q/A 2015 Q2 Quarterly report (amended)

Exhibit 23

 

2005 Sheppard Avenue East, Suite 300

Toronto, Ontario

M2J 5B4, Canada

Phone416-496-1234

Fax 416-496-0125

Web www.mhc-ca.com

Consent of Independent Registered Public Accounting Firm

We hereby consent to the inclusion of our report dated January 28, 2016, relating to our audit of the condensed interim consolidated financial statements of Tribute Pharmaceuticals Canada Inc. (the “Company”) as at and for the period ended June 30, 2015 (the “Report”), in the Company’s Amendment No.1 to the Quarterly Report on Form 10-Q/A for the quarterly period ended June 30, 2015, and to the incorporation by reference of the Report in the Company’s registration statement on Form F-3 (File No. 333-197817), and in the registration statement on Form S-4 (File No. 333-208523) of Aralez Pharmaceuticals Inc.

/s/ McGovern, Hurley, Cunningham, LLP

Chartered Accountants

Licensed Public Accountants

Toronto, Ontario, Canada

January 28, 2016